BGN bresagen limited

Postal Address 8 Dalgleish Street Telephone +61 8 8234 2660PO...

  1. 31,084 Posts.
    Postal Address 8 Dalgleish Street Telephone +61 8 8234 2660
    PO Box 259 Thebarton SA 5031 Facsimile +61 8 8234 6268
    Rundle Mall SA 5000 Australia www.bresagen.com.au Email [email protected]
    BresaGen Limited
    ACN 007 988 767
    ABN 60 007 988 767
    ASX Release 1st February 2005
    BresaGen Update Regarding Company Operations
    BresaGen is pleased to announce that it has made significant progress in procuring third party
    contracts for its protein engineering business in the 3 months since it emerged from voluntary
    administration.
    The Company’s protEcol Contract Services business unit has been in discussions with 12
    Australian and overseas companies regarding process development and manufacture of their
    biologics. As of the end of January, BresaGen has achieved a significant milestone in having
    signed contracts totalling $547,000. The Company has a high level of confidence that a
    number of other contracts will be executed shortly.
    In addition, a collaboration agreement has been executed with an undisclosed overseas
    pharmaceutical company. Commencement of the initial project in the collaboration, valued
    at $1.2 million, is subject to finalisation of commercial terms.
    The Company’s API supply business has also seen an increased demand for its equine and
    human growth hormone products over the same period.
    The increasing interest in BresaGen’s capability and capacity in the area of protein
    expression and process development reflects the level of external confidence and market need
    for the Company’s services.
    For further information contact:
    Dr Wolf Hanisch
    Managing Director
    BresaGen Limited
    Mobile number 0412 339 460
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.